Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2026
    • The 2026 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2026 Leadership
    • 2025 Winners
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • Subscribe

Curemark Moderates Autism Panel at Life Sciences Summit 2010

October 11, 2010 By Bio-Medicine.Org

RYE, N.Y., Oct. 11 /PRNewswire/ — Dr. Joan Fallon, founder and
CEO of Curemark, LLC, (www.curemark.com), a drug
research and development company focused on the treatment of
neurological diseases, moderated the neuroscience roundtable
focused on autism at the Life Sciences Summit 2010, held September
22-23 in Hauppauge, New York.  

Sponsored by the State University of New York at Stony Brook,
Brookhaven National Laboratories and Cold Spring Harbor
Laboratories, the Life Sciences Summit focused on forging
partnerships between biopharmaceutical companies and companies
emerging from academia to accelerate biomedical solutions in areas
including infectious disease, neuroscience, oncology and
regenerative medicine.   In addition to serving as panel
moderator, Dr. Fallon presented an update on Curemark’s autism
treatment CM-AT, currently in Phase III
clinical trials, at the conference’s Emerging Company and
Innovator’s Showcase.

“The Life Sciences Summit brought together researchers,
scientists and representatives of companies working at the
forefront of new medical developments, who shared and exchanged
ideas in this very conducive forum.  The discussion at the
Roundtable highlighted some of the latest research in identifying
possible causes of autism as well promising new therapies,” she
said.  

Participating at the Roundtable entitled “Autism Spectrum
Disorder: Recent Advances in the Development of Symptomatic
Treatments” were Joseph Buxbaum, PhD, MSc, principal investigator,
Laboratory of Molecular Neuropsychiatry, Mount Sinai School of
Medicine; Deborah A. Pearson, PhD, professor, Division of Child and
Adolescent Psychiatry, Department of Psychiatry and Behavioral
Sciences, University of Texas Medical School at Houston; John
Spiro, PhD, senior associate director for research, Simons
Foundation; and Larry J.

‘/>”/>

SOURCE

Related Articles Read More >

The pitch: Cerulean Scientific’s failure-resistant intraventricular catheter
The MIT researcher's implant, LUCID.
MIT researchers design implantable ultrasound-powered drug delivery device to minimize tumor recurrence
A photo of the Paradromics Connexus brain-computer interface on a fingertip.
How Paradromics designed its Connexus brain-computer interface system
An illustration of HITMAN operating in glioblastoma cells.
MIT researchers develop injectable nanodevices that remotely kill brain tumor cells
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2026 Arrowfly, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2026
    • The 2026 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2026 Leadership
    • 2025 Winners
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • Subscribe